Yet, a recent report demonstrated that SOX2 maintains self renewal of murine tumor-initiating osteosarcoma cells which were driven into osteogenic differentiation through increased basal TCF/LEF-signaling after knockdown of SOX2 and lost proliferative capacity [29]. The gene discussed is SOX2; the disease is osteosarcoma.